Andrew Kaplan
Company: Bristol Myers Squibb
Job title: Principal Scientist
Seminars:
Chair: 10:45 am
day: Conference Day Two - Track One
Roundtable Discussion: Investigating the ‘Non-Motor’ Symptoms of Parkinson’s Disease 2:00 pm
More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas. How can we better understand and target the non-motor symptoms of PD? How could non-motor symptoms be used as biomarkers to detect those at high risk for early PD? Moderator Feedback & Audience Debate Moderators will…Read more
day: Conference Day One - Track One
Chair: 10:45 am
day: Conference Day One - Track One
Panel Discussion: Exploring Opportunities in Alpha-Synuclein & Beyond for More Transformative & Efficacious Therapies: What’s Coming Next in Parkinson’s Drug Development? 4:30 pm
Taking learnings from targeting amyloid plaques, what is the rationale for targeting synuclein fibrils? What are the promising PD targets beyond alpha-synuclein? What can we expect to see in the next few years? What are the latest advancements in diagnostic tools like alpha-synuclein PET tracers and what potential do these hold? What are the earlier…Read more
day: Conference Day One PM